Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

An "export-only" exception to pharmaceutical patents in Europe: Should the U.S. follow suit?

Minssen, Timo LU ; Kesselheim, Aaron and Darrow, Jonathan (2019) In Nature Biotechnology 37(1). p.21-22
Abstract
A new European Union policy could increase the supply of legitimate pharmaceuticals in developing countries and thereby minimize the problem of counterfeit medicines, but many challenges remain. This paper describes the proposed European legislation and discusses its' potential strengths, weaknesses, opportunities and threats. Ultimately, we consider if the United States should consider similar policies.
Please use this url to cite or link to this publication:
author
; and
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Medical law, Medicinsk rätt
in
Nature Biotechnology
volume
37
issue
1
pages
2 pages
publisher
Nature Publishing Group
external identifiers
  • scopus:85059503599
ISSN
1087-0156
DOI
10.1038/nbt.4324
language
English
LU publication?
no
id
8a6e56b2-a28d-4447-84ed-77b74bf8282c
date added to LUP
2020-12-16 14:14:54
date last changed
2022-04-26 22:36:56
@article{8a6e56b2-a28d-4447-84ed-77b74bf8282c,
  abstract     = {{A new European Union policy could increase the supply of legitimate pharmaceuticals in developing countries and thereby minimize the problem of counterfeit medicines, but many challenges remain. This paper describes the proposed European legislation and discusses its' potential strengths, weaknesses, opportunities and threats. Ultimately, we consider if the United States should consider similar policies.}},
  author       = {{Minssen, Timo and Kesselheim, Aaron and Darrow, Jonathan}},
  issn         = {{1087-0156}},
  keywords     = {{Medical law; Medicinsk rätt}},
  language     = {{eng}},
  month        = {{01}},
  number       = {{1}},
  pages        = {{21--22}},
  publisher    = {{Nature Publishing Group}},
  series       = {{Nature Biotechnology}},
  title        = {{An "export-only" exception to pharmaceutical patents in Europe: Should the U.S. follow suit?}},
  url          = {{http://dx.doi.org/10.1038/nbt.4324}},
  doi          = {{10.1038/nbt.4324}},
  volume       = {{37}},
  year         = {{2019}},
}